At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 10 enrolled
Drug / intervention
PMP-300E +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PMP-300E: Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.
In Brief
A Phase 3 clinical trial evaluating PMP-300E and In-lab PSG for Obstructive Sleep Apnea. Completed, enrolled 10 participants across 2 sites.
Detailed Summary
Validation of Portable Monitoring Device PMP-300E for Identification of Obstructive Sleep Apnea.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2008
First PostedJun 2011
Primary CompletionMay 2012
Study CompletionJun 2012
TodayJul 2026
First PostedJun 2, 2011
Enrollment StartJun 1, 2008
Primary CompletionMay 1, 2012
Study CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 15.1 years ago
Interventions
PMP-300Edevice
Data collected from Level 3 device
In-lab PSGdevice
Data collected from Type I In-Lab Polysomnography